Munchkin Launches Revolutionary Nipple Shield Designed to Increase Breastfeeding Rates Worldwide
Munchkin Flow Nipple Shield + gives moms visual confirmation of milk flow
LOS ANGELES, March 5, 2025 /PRNewswire/ -- Munchkin Inc. ('Munchkin'), the most loved baby lifestyle brand in the world, owned by WHY Brands Inc. ('WHY'), today unveiled its patented Flow Nipple Shield +, the world's first nipple shield that allows moms to see their milk flow to their babies while nursing. The Flow Nipple Shield + marks the first in a series of innovative infant feeding products Munchkin will launch this year as it expands into the infant nutrition space.
By providing nursing moms with visual confirmation of milk flow, the Flow Nipple Shield + eliminates doubt, boosts confidence, provides insights and extends breastfeeding sessions. Munchkin's ongoing U.S. clinical research study of 301 moms with access to the Flow Nipple Shield + is remarkable: nearly 92.8% of participating moms have met or surpassed their breastfeeding goals with an impressive 93.5% of the Flow Nipple Shield + users continuing to breastfeed 6 months postpartum. The majority of the Flow Nipple Shield + users also report increased confidence in their breastfeeding ability.
'The Flow Nipple Shield + is a true testament to our commitment to innovation, and our passion for supporting maternal health and infant nutrition,' said Steven B. Dunn, founder, chairman and CEO of WHY. 'The Flow Nipple Shield + is poised to revolutionize the breastfeeding experience for mothers to help increase breastfeeding rates worldwide.'
This transformative lactation companion addresses one of the most common concerns among breastfeeding mothers: the perception of insufficient milk supply. Standout features include:
Innovative Design: The Flow Nipple Shield + is the first-ever, patented nipple shield with a built-in milk channel that allows breastfeeding moms to see their baby's nourishment in real-time, supporting them in meeting or exceeding their breastfeeding goals.
Uncompromising Safety: The Flow Nipple Shield + meets the highest standards of maternal and infant safety, crafted from 100% BPA-free food-grade silicone, and is durable enough for up to 200 uses.
Inclusive Sizing: Knowing each mom is unique, the Munchkin Flow Nipple Shield + comes in 4 sizes, 16, 20, 24, and 28mm.
Unmatched Convenience: The Munchkin Flow Nipple Shield + Starter Kit comes with a specialized cleaning syringe, and compact travel and sterilizing case for moms on the go.
'By addressing common breastfeeding concerns with tangible, visual feedback, we're eliminating one of the challenges and sources of frustration that every breastfeeding mom faces,' said Kristin Pagano, GM of Infant Nutrition at Munchkin, and mom of two. 'The Flow Nipple Shield + will be a game-changer for breastfeeding moms, boosting their confidence and extending how long they breastfeed their infants.'
To make the Flow Nipple Shield + more broadly accessible, Munchkin has committed to donating up to 50,000 Flow units to WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) chapters throughout the U.S. this year. WIC is a division of the USDA's Food & Nutrition Services that provides breastfeeding support, touching more than 43% of births in the U.S. with its services.
The Munchkin Flow Nipple Shield + Starter Kits (shield, cleaning syringe, and travel case) will be available for purchase for $39.99 at Munchkin.com, Target and Walmart.
About Munchkin Inc.
For more than 30 years, Munchkin Inc., the baby lifestyle brand owned by WHY Brands Inc, has produced innovative products and functional gear for children and their caregivers. Munchkin has over 350+ patents to date, and more than 250 international product and brand design awards. Munchkin products are sold in more than 50 countries and have received over 1.45 million five-star reviews.
Munchkin has been awarded Great Place to Work for four consecutive years and is recognized as a 2024 Best Places to Work by Built In. Munchkin has been honored on Fast Company's annual 'Brands That Matter' list for two consecutive years, including 2024, and ranked number eight on Fortune's list of 'Most Innovative Companies' in 2023.
As the only baby brand in the United Nations Global Compact, the company prioritizes corporate social responsibility with commitments to environmental protection and animal welfare, which are highlighted in its annual Sustainability Report. Learn more at www.WHYBrands.com and www.Munchkin.com.
About WHY Brands Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Rad AI Named to CNBC Disruptor 50 List For Pioneering Generative AI in Healthcare
Recognition comes amid rapid growth, with Rad AI recently securing $68 million in Series C Funding and ranking 19th on the Deloitte Fast 500. SAN FRANCISCO, June 10, 2025 /PRNewswire/ -- Rad AI, the leader in generative AI for healthcare, today announced it was named to the 2025 CNBC Disruptor 50 list. The annual list recognizes the most innovative, fast-growing private companies that are disrupting established industries using breakthrough technologies. This recognition further solidifies Rad AI's position as the leader in pioneering AI-driven solutions that improve radiologist efficiency, reduce burnout, and enhance patient care. The CNBC Disruptor 50 recognition follows a remarkable period of company growth that includes several recent milestones: Closed $68M Series C, including strategic investments from some of the nation's most respected health systems. Ranked #19 on the 2024 Deloitte Fast 500. "Being named to the CNBC Disruptor 50 list is an incredible honor for Rad AI," said Doktor Gurson, CEO and co-founder of Rad AI. "Since our founding in 2018, we've believed that AI should empower—not replace—radiologists. Our mission has always been to deliver AI-driven solutions that save time, reduce burnout, and elevate patient care. This recognition from CNBC not only highlights our impact in transforming healthcare through AI, but also reinforces our ongoing commitment to creating meaningful, lasting change in the lives of physicians and patients alike." Today, Rad AI is the leading provider of generative AI solutions for radiology workflow optimization and patient follow-up management, with its solutions trusted by over 50% of U.S. health systems and 9 of the 10 largest radiology practices in the country. Rad AI was the first company to deploy large language model (LLM)-based generative AI into radiology workflows with its groundbreaking Rad AI Impressions solution. As the company continues to lead innovation in healthcare AI, it is rapidly expanding its network of strategic partnerships and accelerating efforts to bring its transformative technology to more providers across the globe. Rad AI is making significant investments in partner support, advancing product innovation, and scaling its AI-powered platform to additional health systems and radiology practices. To learn more about Rad AI's solutions, visit About Rad AI Rad AI is the leader in generative AI solutions for radiology, transforming the way radiologists work and improving patient care. The company's flagship product, Rad AI Reporting, streamlines radiology reporting with AI-driven technology and empowers radiologists to achieve greater efficiency, accuracy, and satisfaction. Rad AI Impressions, the company's pioneering product, established Rad AI as an innovator in generative AI for radiology; as the first generative AI application to achieve widespread adoption in radiology, it is now trusted by thousands of U.S. radiologists. Rad AI Continuity, the most comprehensive solution of its kind, provides AI-driven patient follow-up. Rad AI is the fastest-growing radiologist-led AI company and has been recognized as one of the most promising healthcare AI companies by CB Insights (Digital Health 50, AI 100) and AuntMinnie (Best New Radiology Software). Rad AI was named the 19th fastest-growing company in North America on the Deloitte Fast 500. Most recently, in April 2025, Rad AI was named the 4th fastest-growing private company on the Inc. Regionals Pacific list. Learn more about Rad AI at or on LinkedIn at PR Contact: Wei Ting Hsieh, Rad AI, View original content to download multimedia: SOURCE Rad AI Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Southwest General Partners with Notable to Close Care Gaps and Redefine Patient Access
The health center will leverage Notable's AI Platform to automate highly manual processes, including registration, intake, and care gap outreach SAN MATEO, Calif., June 10, 2025 /PRNewswire/ -- Notable, the leading healthcare AI platform for transforming workforce productivity, today announced a new partnership with Southwest General Health Center, a private, not-for-profit acute care facility in Middleburg Heights, Ohio. Southwest General will deploy Notable's platform to meet its patients where they are, creating an easier access point for care. Registration and intake are highly manual processes that overwhelm staff and provider workloads, creating backlogs and delays in patient care. Care gap closure outreach, which entails staff proactively reaching out to patients to schedule care, such as overdue colon cancer, breast cancer, or heart disease screenings, adds an additional administrative burden. This traditionally manual task often creates long worklists of waiting calls, meaning patients may not receive important preventative care in a timely manner. With Notable, Southwest General will use AI Agents to: Send reminders to confirm, cancel, or reschedule appointments Verify and collect any additional information needed to make the check-in process seamless Proactively reach out to patients, in their preferred language and communication method, to schedule outstanding care opportunities at their convenience Help patients navigate their healthcare needs, providing a smooth and intuitive patient experience "At Southwest General, we're committed to redefining the patient experience through innovation and compassion," said Jae Zayed, Chief Information Officer at Southwest General. "As a community-based hospital, our partnership with Notable allows us to make care more accessible and personalized—starting well before a patient steps through our doors. By streamlining appointment preparation and simplifying engagement, we're excited to bring a more seamless, connected experience to the communities we serve." Southwest General aims to be its community's first choice of care for advanced medicine and an exceptional healthcare experience. It leads with innovation to achieve this vision, and using Notable to transform its workforce and streamline operations allows staff to focus more time and attention on unparalleled patient care. "At the end of the day, providing a high level of care and ease of access to healthcare are top goals of any healthcare system," said Pranay Kapadia, CEO at Notable. "With the unique ability of our AI Platform to automate these processes, reducing friction along the patient journey, we can help Southwest General exceed those expectations while eliminating burdensome manual work for staff. When a hospital can meet its patients where they are, the results are truly transformative." For more information on how Notable can personalize and streamline care for patients, visit About NotableDeployed at over 12,000 sites of care, Notable is the leading healthcare AI Platform for transforming workforce productivity. Through Notable, millions of once-manual tasks are automated daily in a safe, secure, end-to-end AI Platform that optimizes workforce efficiency and productivity, cuts operational costs, eliminates fragmentation, and enhances the patient experience. From patient access and member enrollment to revenue cycle management and more, our AI Agents reduce administrative burdens so your staff, providers, and patients can focus on what matters most. Notable is backed by leading investors, including ICONIQ Growth, Greylock Partners, F-Prime, Oak HC/FT, Maverick Ventures, and 8VC. Find out why healthcare providers of all sizes, including Intermountain Health, Medical University of South Carolina, North Kansas City Hospital, and more, have joined Notable on its mission to simplify and optimize healthcare for humanity at About Southwest GeneralSouthwest General is a private, not-for-profit, 368-bed acute care facility located in Middleburg Heights, Ohio. Founded in 1920, Southwest General is home to nationally recognized physicians with full access to state-of-the-art technology. Southwest General has a deep commitment to providing personalized care and building a healthy future for the patients, families and communities it serves. For more information, visit or find Southwest General on Facebook, Instagram, YouTube and X. View original content to download multimedia: SOURCE Notable
Yahoo
2 hours ago
- Yahoo
Opioid, Opiate, and Fentanyl Medical Treatment Without Medication Resembles Malpractice, Claims Addiction Treatment Authority In New Book
ROSWELL, N.M., June 10, 2025 /PRNewswire/ -- Board-certified nurse practitioner and recognized authority on addiction recovery, is calling for a shift in medical standards around opioid and fentanyl addiction. Trent Carter argues that refusing to offer Medication-Assisted Treatment (MAT) to patients is not only negligent. It may be akin to medical malpractice. "Too many providers still avoid MAT altogether," said Carter. "That's not just a missed opportunity. It's a failure of care." MAT involves the use of FDA-approved medications such as buprenorphine and naltrexone to reduce cravings, ease withdrawal symptoms, and stabilize brain chemistry. These treatments make it possible for patients to fully engage in counseling, develop life goals, and move toward long-term recovery. According to Carter, MAT helps patients: Access flexible treatment options, including long-acting injections or take-home medications. Reduce the risk of relapse and overdose with safe, regulated medications. Build trust and confidence in the recovery process. Stabilize physically so they can benefit from behavioral therapy. Despite these benefits, many doctors still fail to offer MAT, putting patients at greater risk of relapse and death. Carter warns that this omission may violate medical ethics and legal standards. "MAT is not an optional extra. It's the gold standard," Carter said. "Withholding it increases harm and limits a patient's right to informed consent." Carter outlines his case in his new book The Recovery Tool Belt, which breaks down the science of opioid addiction and explains why medication must be the foundation of care, not an afterthought. For interviews or press inquiries, please contact BrightRay Publishing at publicist@ View original content to download multimedia: SOURCE BrightRay Publishing Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
